Home > Insider Trading > Filing (0001104659-19-005835)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1509745	Leap Therapeutics Inc.	LPTX	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1490245	Healthcare Ventures Ix, L.p.	C/O Leap Therapeutics, Inc. 47 Thorndike Street Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1697027	Healthcare Partners Ix, L.p.	C/O Leap Therapeutics, Inc. 47 Thorndike Street Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1698828	Healthcare Partners Ix, Llc	C/O Leap Therapeutics, Inc. 47 Thorndike Street Suite B1-1 Cambridge MA 02141	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-05	571,428	$1.75	4,144,804	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.001 Par Value Per Share	Warrant (Right to Buy)	Acquisiton	2019-02-05	571,428	$0.00	571,428	$1.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
571,428	2019-02-05	2026-02-05	No	4	P	Direct

Footnotes

The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities.
The reported securities were included with the 571,428 shares of common stock purchased by the reporting persons for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock.